This is a report targeted towards community health centers that focuses on preventing the spread of infectious diseases related to intravenous drug use, institutional challenges, integration of opioid use disorder (OUD) treatment into primary care, and sharing information with the community.

This report is a literature review meant to address the gap in knowledge in terms of health inequities present in access to treatment for substance use disorder. The authors analyzed currently available sources on the topic and found that more attention to upstream factors of substance use disorder would have a positive impact on downstream factors including overdose. 

This paper outlines a study which aimed to identify the challenges to implementing peer recovery support services in the emergency department setting for individuals presenting with opioid use disorder. The authors selected relevant stakeholders with hospital related roles or expertise on peer support workers to interview for qualitative data collection. The results of this study identified several challenges at the system, hospital, and individual level. 

From AHRQ (Volume 2), a resource that provides tools and strategies for rural primary care providers to: 1) prevent opioid use disorder (OUD); 2) educate on medications for opioid use disorder (MOUD); 3) implement MOUD; and 4) prevent opioid overdose.  

A website that describes a team-based approach to improving the management of patients on long-term opioid therapy in primary care. This approach is focused on six building blocks, has an implementation guide, and has links to tools and resources. 

This issue brief, a product of several collaborating organizations including IDSA, HIVMA and PIDS, identifies policy issues and provides comprehensive recommendations for addressing infectious diseases related to opioid use disorder. 

The Institute for Research, Education, & Training in Addictions (IRETA) is a public health organization that provides free trainings, webinars, case studies of interventions, and prescriber education to help people respond to substance use and related problems. 

This report provides summary guidance and recommendations from CDC and the U.S. Department of Health and Human Services for prevention and control of human immunodeficiency virus (HIV) infection, viral hepatitis, sexually transmitted diseases (STDs), and tuberculosis (TB) for persons who use drugs illicitly. It also summarizes existing evidence of effectiveness for practices to support delivery of integrated prevention services.

This is an academic paper discussing The Opioid Initiative, launched in Oregon in 2015, which focuses on integrating efforts to improve patient care and safety, and population health, by increasing access to nonopioid pain treatment, supporting medications for opioid use disorder and naloxone access for people taking opioids, decreasing opioid prescribing, and using data to inform policies and interventions. This state initiative has shown promising results. 

A toolkit from the National Resource Center for Academic Detailing (NaRCAD) the provides resources for academic detailing of opioid prescribing and treatment with medications for opioid use disorder (MOUD), including links to previous literature, resources, and patient education material.

This is a publication by the National Academy for State Health Policy (NASHP) that highlights strategies states are using to better deploy emergency intervention to reduce opioid overdose deaths, improve access to care, and provide better treatment services in rural areas.

This report also describes sustainable financing structures to support these strategies and services. There is also mention of unique rural barriers and how to overcome them as well as case studies of comprehensive community responses.

This is a website that provides summary documents on how pharmacists are responding to the opioid crisis, including preventing opioid misuse, increasing access to medications of opioid use disorder, and providing harm reduction services. These documents describe success stories as well as clinical and systemic barriers faced by pharmacists.